Response to Jackson and Harris, 2022;179:102417

Simple item page
dc.contributor.authorGibson, R.A.
dc.contributor.authorMakrides, M.
dc.contributor.authorSullivan, T.
dc.contributor.authorYelland, L.N.
dc.contributor.authorBest, K.P.
dc.date.issued2022
dc.descriptionShort communication
dc.description.abstractAbstract unavailable
dc.description.statementofresponsibilityR.A. Gibson, M. Makrides, T. Sullivan, L.N. Yelland, K.P. Best
dc.identifier.citationProstaglandins Leukotrienes and Essential Fatty Acids, 2022; 182:102454-1-102454-2
dc.identifier.doi10.1016/j.plefa.2022.102454
dc.identifier.issn0952-3278
dc.identifier.issn1532-2823
dc.identifier.orcidGibson, R.A. [0000-0002-8750-525X]
dc.identifier.orcidMakrides, M. [0000-0003-3832-541X]
dc.identifier.orcidSullivan, T. [0000-0002-6930-5406]
dc.identifier.orcidYelland, L.N. [0000-0003-3803-8728]
dc.identifier.orcidBest, K.P. [0000-0002-7653-5074]
dc.identifier.urihttps://hdl.handle.net/2440/146256
dc.language.isoen
dc.publisherElsevier BV
dc.rights© 2022 Elsevier Ltd. All rights reserved.
dc.source.urihttps://doi.org/10.1016/j.plefa.2022.102454
dc.subjectOmega-3 fatty acids; DHA; Pregnancy
dc.subject.meshFatty Acids, Omega-3
dc.subject.meshFatty Acids, Omega-6
dc.titleResponse to Jackson and Harris, 2022;179:102417
dc.typeJournal article
pubs.publication-statusPublished

Files

Collections

Research Outputs